Cargando…
Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288735/ http://dx.doi.org/10.1186/2051-1426-2-S3-P74 |
| _version_ | 1782352016566124544 |
|---|---|
| author | Greene, Julia Schneble, Erika Berry, John Trappey, Alfred Vreeland, Timothy Clifton, Guy McGuire, William Maxwell, George Ponniah, Sathibalan Peoples, George |
| author_facet | Greene, Julia Schneble, Erika Berry, John Trappey, Alfred Vreeland, Timothy Clifton, Guy McGuire, William Maxwell, George Ponniah, Sathibalan Peoples, George |
| author_sort | Greene, Julia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288735 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887352015-01-15 Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence Greene, Julia Schneble, Erika Berry, John Trappey, Alfred Vreeland, Timothy Clifton, Guy McGuire, William Maxwell, George Ponniah, Sathibalan Peoples, George J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288735/ http://dx.doi.org/10.1186/2051-1426-2-S3-P74 Text en Copyright © 2014 Greene et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Greene, Julia Schneble, Erika Berry, John Trappey, Alfred Vreeland, Timothy Clifton, Guy McGuire, William Maxwell, George Ponniah, Sathibalan Peoples, George Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title | Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title_full | Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title_fullStr | Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title_full_unstemmed | Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title_short | Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence |
| title_sort | preliminary results of the phase iia trial of a folate binding protein (fbp) adjuvant cancer vaccine (e39+gm-csf) in ovarian and endometrial cancer patients to prevent recurrence |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288735/ http://dx.doi.org/10.1186/2051-1426-2-S3-P74 |
| work_keys_str_mv | AT greenejulia preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT schnebleerika preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT berryjohn preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT trappeyalfred preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT vreelandtimothy preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT cliftonguy preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT mcguirewilliam preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT maxwellgeorge preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT ponniahsathibalan preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence AT peoplesgeorge preliminaryresultsofthephaseiiatrialofafolatebindingproteinfbpadjuvantcancervaccinee39gmcsfinovarianandendometrialcancerpatientstopreventrecurrence |